Delivery Order SPE2DB24D2101-SPE2DB24FKFDF

Award Date 7/11/24
Potential Completion Date 7/12/24
Potential Value $9.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $22,748.00 Firm Fixed Price Delivery Order for the supply of JARDIANCE 10 MG TABLET 90S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency of the U.S. government, with a completion date of July 12, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with DLA Troop Support Medical to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,067.16 firm fixed price delivery order is for the supply of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of April 8, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $19,608.77 firm-fixed-price delivery order contract is for the supply of JARDIANCE 25 MG TABLET 90S, with a completion date of June 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,067.49, is a delivery order for the product "JARDIANCE 25 MG TABLET 90S" with a completion date of December 18, 2023. The contract is a firm fixed-price type with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, involves the delivery of JARDIANCE 25 MG TABLET 90S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,967.56, is a Firm Fixed Price Delivery Order that runs through May 2, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide a...
This federal contract award, valued at $10,099.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of JARDIANCE 10 MG TABLET 90S, with an ultimate completion date of January 13, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $9,515.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of July 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a delivery order worth $32,969.39 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4558724906 - JARDIANCE 10 MG TABLET 90S to the Medical Supply Chain, a component of the Department of Defense (DOD). The $1,830.50 firm fixed-price delivery order contract has an ultimate completion date of October 11, 2022 and was awarded on October 10, 2022. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $5,527.44 and runs from June 14, 2024 to June 17, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB24FKFDF
    Delivery Order

This federal contract award, valued at $9,848.62, was granted to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of 4565119631 - JARDIANCE 10 MG TABLET 90S, a pharmaceutical product, to support the Department of Defense's medical treatment programs and facilities.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract does not have a set-aside designation.

Generated 10/10/24, 9:32 AM